Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
Author(s)
Spaide, Richard F.; Jaffe, Glenn J.; Sarraf, David; Freund, K. Bailey; Sadda, Srinivas R.; Staurenghi, Giovanni; Waheed, Nadia K.; Chakravarthy, Usha; Rosenfeld, Philip J.; Holz, Frank G.; Souied, Eric H.; Cohen, Salomon Y.; Querques, Giuseppe; Ohno-Matsui, Kyoko; Boyer, David; Gaudric, Alain; Blodi, Barbara; Baumal, Caroline R.; Li, Xiaoxin; Coscas, Gabriel J.; Brucker, Alexander; Singerman, Lawrence; Luthert, Phil; Schmitz-Valckenberg, Steffen; Schmidt-Erfurth, Ursula; Grossniklaus, Hans E.; Wilson, David J.; Guymer, Robyn; Yannuzzi, Lawrence A.; Chew, Emily Y.; Csaky, Karl; Monés, Jordi M.; Pauleikhoff, Daniel; Tadayoni, Ramin; Fujimoto, James G; ... Show more Show less
DownloadPublished version (9.974Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Purpose: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design: Consensus meeting. Participants: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. Methods: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. Main Outcome Measures: A consensus classification of neovascular AMD. Results: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. Conclusions: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
Date issued
2020-05Department
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer ScienceJournal
Ophthalmology
Publisher
Elsevier BV
Citation
Spaide, Richard F. et al. "Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data." 127, 5 (May 2020): P616-636 © 2019 American Academy of Ophthalmology
Version: Final published version
ISSN
0161-6420